RESUMO
AIMS: To elucidate varicella zoster virus (VZV)-specific cell-mediated immunity and humoral immunogenicity against live attenuated Oka varicella zoster vaccine concurrently vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in elderly people with diabetes mellitus. METHODS: This double-blind randomized controlled single-centre study of 60-70-year-old people with diabetes compared immunity and safety profiles 3 months after one dose of varicella zoster vaccine or placebo. PPSV23 was immunized simultaneously. Primary analysis evaluated cell-mediated immunity using the VZV skin test. Secondary analyses were a VZV interferon-γ enzyme-linked immunospot (ELISPOT) assay and immunoadherence haemagglutination test. Adverse experiences were recorded using diary questionnaires. RESULTS: By intent-to-treat analysis, 27 participants with diabetes who had been administered the vaccine were compared with 27 participants who were given a placebo. Changes in skin test scores were 0.41 ± 0.80 and 0.11 ± 0.93 (P = 0.2155), and geometric mean fold rises of the ELISPOT counts were 1.2 [95% confidence interval (CI) 0.2, 7.9] and 1.2 (95% CI 0.2, 7.3) (P = 0.989) in the vaccine and placebo groups, respectively. The geometric mean titre did not increase 3 months after vaccination in either group. No vaccination-related severe adverse experience was reported and no participant developed herpes zoster. DISCUSSION: Our previous results demonstrated that varicella zoster vaccine safely enhanced VZV-specific immunity in elderly people with or without diabetes. The results of this study showed that varicella zoster vaccine can be used safely, but it cannot boost virus-specific immunity in elderly people with diabetes when administered with concurrent PPSV23. Alternative strategies are needed to prevent VZV-associated diseases in this population.
Assuntos
Diabetes Mellitus/imunologia , Vacina contra Herpes Zoster/imunologia , Herpes Zoster/imunologia , Imunidade Celular/imunologia , Imunogenicidade da Vacina/imunologia , Idoso , Método Duplo-Cego , ELISPOT , Feminino , Herpes Zoster/prevenção & controle , Vacina contra Herpes Zoster/uso terapêutico , Herpesvirus Humano 3/imunologia , Humanos , Reação no Local da Injeção/epidemiologia , Reação no Local da Injeção/etiologia , Testes de Liberação de Interferon-gama , Masculino , Pessoa de Meia-Idade , Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas/uso terapêutico , Prurido/induzido quimicamente , Prurido/epidemiologia , Testes CutâneosRESUMO
AIM: To investigate the relationship between plasma betatrophin concentrations and insulin secretion capacity in people with Type 2 diabetes. METHODS: Glucagon stimulation tests (1 mg) were performed in 70 people with Type 2 diabetes after an overnight fast. Plasma betatrophin concentrations were measured using an enzyme-linked immunosorbent assay. Insulin secretion capacity was evaluated by measuring increments of C-peptide concentration in response to glucagon stimulation, and creatinine clearance was determined by comparing creatinine concentrations in serum and 24-h urine samples. RESULTS: Plasma betatrophin concentrations were positively correlated with duration of Type 2 diabetes (r = 0.34, P = 0.003), and negatively correlated with increments of C-peptide concentration (r = 0.37, P = 0.001) and creatinine clearance (r = 0.37, P = 0.001). The correlation with increments of C-peptide concentration remained significant after adjustment for age and duration of Type 2 diabetes (r = 0.25, P = 0.037). Multivariate analysis identified age and increments of C-peptide concentration as independent factors associated with plasma betatrophin levels. CONCLUSION: Plasma betatrophin levels inversely correlate with insulin secretion capacity, suggesting that betatrophin levels are regulated by insulin secretion capacity in humans.
Assuntos
Diabetes Mellitus Tipo 2/sangue , Glucagon/farmacologia , Células Secretoras de Insulina/metabolismo , Insulina/sangue , Hormônios Peptídicos/sangue , Idoso , Proteína 8 Semelhante a Angiopoietina , Proteínas Semelhantes a Angiopoietina , Biomarcadores/sangue , Peptídeo C/sangue , Creatinina/sangue , Creatinina/urina , Diabetes Mellitus Tipo 2/fisiopatologia , Feminino , Humanos , Células Secretoras de Insulina/fisiologia , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estimulação Química , Fatores de TempoRESUMO
Children with severe motor intellectual disabilities (SMID) are at high risk of death from acute viral lower respiratory tract infections (LRTI). Although respiratory syncytial virus (RSV) is the most common cause of viral LRTI in children, there have been a few reports on the relationship between SMID and the severity of RSV-LRTI. The aim of the present study is to assess the influence of RSV-LRTI in children with SMID. A case-control study composed of children with SMID (n = 18) and previously healthy children (n = 43) less than 16 years old hospitalized for RSV-LRTI was performed during five consecutive RSV seasons. The clinical presentation and the laboratory data in the SMID group were compared with those in the non-SMID group. In the bivariate analysis, the median age of the SMID group was higher than that of the non-SMID group (p = 0.002). Children with SMID had an increased risk for ventilation support (p = 0.057). The count of neutrophils in the SMID group was significantly increased (p = 0.012), whereas the proportion of bacterial co-infection was lower than that in the non-SMID group (p = 0.005). Multivariate logistic analysis showed that SMID was associated with longer oxygen usage [>7 days: odds ratio (OR) 5.309, p = 0.033]. The present study revealed that children with SMID were prone to developing hypoxia by RSV-LRTI. The strategies for the treatment and prevention of RSV infection need to be improved in SMID children.
Assuntos
Pessoas com Deficiência , Deficiência Intelectual/complicações , Paraplegia/complicações , Infecções por Vírus Respiratório Sincicial/epidemiologia , Vírus Sincicial Respiratório Humano/isolamento & purificação , Estudos de Casos e Controles , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Infecções por Vírus Respiratório Sincicial/patologia , Estudos Retrospectivos , Fatores de RiscoRESUMO
BACKGROUND: Recently, it has been reported that the incidence of primary aldosteronism (PA) among patients with hypertension is much more frequent than previously reported. AIM: In the present study, we investigated the frequency and features of PA associated with subclinical Cushing syndrome (SCS). MATERIAL AND METHODS: Subjects included consecutive patients (no.=39) who were diagnosed as PA and performed adrenal venous sampling between 2003 and 2011 in our institute. RESULTS: In 39 subjects who were diagnosed as PA, 29 patients were operated and 5 cases (12.8%) showed no suppression in low-dose dexamethasone suppression test. Four cases of them were demonstrated to be associated with SCS, and one was associated with overt Cushing syndrome (CS). Post-operatively, 3 cases received replacement therapy of hydrocortisone, while others did not. Pathological findings indicated the diagnosis of aldosterone-producing adenoma in 4 cases associated with SCS, and of idiopathic hyperaldosteronismin in one case associated with overt CS. In all 5 cases, immunohistochemical analysis demonstrated the immunoreactivities of both 3ßHSD and P450c17 in the adrenocortical tumors, the marked cortical atrophy in the zona fasciculata and reticularis, the decreased dehydroepiandrosterone sulfotransferase expression, and suppression of hypothalamo- pituitary-adrenal axis indicating the autonomous secretion of cortisol from the tumor. CONCLUSIONS: The present study suggests that PA is frequently associated with SCS with prevalence of more than 10%, justifying the routine examinations for SCS in PA cases.
Assuntos
Neoplasias do Córtex Suprarrenal/complicações , Síndrome de Cushing/complicações , Hiperaldosteronismo/etiologia , Adenoma/diagnóstico , Neoplasias das Glândulas Suprarrenais/diagnóstico , Adulto , Dexametasona , Feminino , Humanos , Hidrocortisona/metabolismo , Masculino , Pessoa de Meia-IdadeRESUMO
AIM: The aim of this study was to determine the correlation between the growth hormone (GH)-insulin-like growth factor-I (IGF-I) axis and glucose intolerance in acromegaly during the early postoperative period. SUBJECTS AND METHODS: The study included 20 patients with acromegaly caused by GH-secreting pituitary adenoma who received transsphenoidal surgery in our hospital. Glucose tolerance was evaluated with oral glucose tolerance tests (OGTTs) performed during pre- and early postoperative periods (9 [7-18] days after surgery). Homeostasis model assessment of insulin resistance (HOMA-IR) and insulinogenic index (IGI) were calculated, and correlation analyses were performed between these values and the GH-IGF-I axis. Patients were divided according to postoperative changes of the axis, and glucose tolerance was compared between the groups. RESULTS: In preoperative OGTTs, nine patients had impaired glucose tolerance and two had diabetes mellitus patterns. Postoperatively, significant reduction was observed both in fasting plasma glucose levels (p<0.01) and in HOMA-IR (p<0.01), whereas IGI showed no significant change. HOMA-IR was significantly correlated with serum IGF-I levels both before (r=0.83, p<0.01) and after (r=0.57, p<0.01) surgery, although it was not correlated with serum GH levels. Patients who achieved more than 50% postoperative reduction in serum IGF-I levels showed significant improvement in OGTTs results (p<0.05). CONCLUSIONS: In patients with acromegaly, serum IGF-I levels, but not GH levels, were significantly correlated with insulin resistance. Early postoperative improvement of glucose tolerance is observed in patients who achieved postoperative reduction in serum IGF-I levels.
Assuntos
Acromegalia/cirurgia , Biomarcadores/sangue , Resistência à Insulina , Fator de Crescimento Insulin-Like I/análise , Procedimentos Neurocirúrgicos , Seio Esfenoidal/cirurgia , Acromegalia/sangue , Acromegalia/etiologia , Adulto , Idoso , Feminino , Seguimentos , Hormônio do Crescimento Humano/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/complicações , Período Pós-Operatório , Prognóstico , Adulto JovemRESUMO
AIMS: It has been recognized that blood pressure shows a seasonal variation, but it remains unknown whether diabetic nephropathy shows a seasonal variation. In the present study, we investigated the change in urinary albumin/creatinine ratio in relation to the season in Japanese patients with Type 2 diabetes. METHODS: A total of 430 subjects (275 male, 155 female) with Type 2 diabetes and early nephropathy (defined by UACR 30-300 mg/g creatinine) were included. One year was divided into four seasons and each season was defined as winter (December-February), spring (March-May), summer (June-August), and fall (September-November), and systolic and diastolic blood pressure, serum creatinine levels, and the urinary albumin/creatinine ratio were examined. The estimated glomerular filtration rate was also calculated and evaluated. RESULTS: The mean age (± SE) was 64.8 ± 0.8 years. The mean systolic blood pressure was significantly higher in winter than in summer (136 ± 0.68 vs. 133 ± 0.68 mmHg, P < 0.001). The urinary albumin/creatinine ratio showed a significantly higher value in winter than in summer (72.8 ± 4.4 vs. 54.6 ± 3.4 mg/g creatinine, P < 0.001). The curve of seasonal variation of this ratio showed a similar change to that of systolic blood pressure. No significant seasonal variation was observed in estimated glomerular filtration rate and diastolic blood pressure. CONCLUSIONS: Our results suggest that there is a hitherto unknown seasonal variation in the urinary albumin/creatinine ratio, and that it may be necessary to consider this seasonal change, especially when performing an intervention study of nephropathy.
Assuntos
Albuminúria/urina , Creatinina/urina , Diabetes Mellitus Tipo 2/urina , Nefropatias Diabéticas/urina , Taxa de Filtração Glomerular , Hemoglobinas Glicadas/metabolismo , Albuminúria/fisiopatologia , Povo Asiático , Pressão Sanguínea , Diabetes Mellitus Tipo 2/fisiopatologia , Nefropatias Diabéticas/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estações do Ano , Fatores de TempoRESUMO
Time-series sediment traps were deployed for an entire year at three depths (890, 2590, and 3560 meters) at a deepwater station (3860 meters) in the Panama Basin. The amount of horizontal and lithogenic particulate material arriving at the three depths was seasonally pulsed and directly reflected changes in surface primary production. Two spikes of organic flux were simultaneously recorded at all three depths: (i) a period of high productivity during regional upwelling in February through March and (ii) an unusual bloom of a single species of coccolithophorid during June through July. This latter spike delivered approximately 25 grams of coccolith per square meter of area at a depth of 3860 meters during less than 60 days. The flux of lithogenic particles increased with increasing depth and was seasonally correlated to surface production and current direction, and not to the detritus discharged in river flow. The data suggest that suspended clays are efficiently scavenged from the water column by rapidly sinking organic aggregates.
RESUMO
The relative importance of the pelagic flux of aragonite, as compared to calcite, to the deep-sea floor has been evaluated by means of a quantitative x-ray diffraction study of samples collected from sediment traps and from an unusually shallow portion of the open Atlantic Ocean (the Rio Grande Rise). The results suggest that the aragonite flux constitutes at least 12 percent of the total flux of calcium carbonate on a worldwide basis. The presence of high-magnesium calcite in several samples suggests that some of the calcareous material falling to the deep-sea floor may be derived from the long-distance transport of debris from shallow-water beenthic organisms as well as from the settling of planktonic remains. This observation supports the contention that 12 percent represents a minimum value. Aragonite and high-magnesium calcite transported laterally from shallow-water regions, upon dissolution during settling into deeper water, may contribute to the neutralization of excess anthropogenic carbon dioxide added to the oceans.
RESUMO
The skeletons of phaeodarian Radiolaria transport and redistribute silica to the tropical deep oceans by dissolving in the water column and on the sea floor. The skeletons are initially solid but within a few days to months become progressively more porous while settling through the water column. Phaeodarian Radiolaria are rarely preserved in the bottom sediments; in contrast, polycystine Radiolaria are the dominant Radiolaria preserved in the fossil record. This preservational difference may be due to differences in skeletal constituents.
RESUMO
The results of an in situ study of calcite dissolution in the Panama Basin indicate that the rate of dissolution in the water column increases suddenly below a water depth of about 2800 meters. This coincides with the depth at which the calcium carbonate content of surface sediments begins to decrease rapidly or the sedimentary lysocline. Since this level of increased dissolution both in the water column and on the sea floor does not appear to be related to the transition from supersaturation to undersaturation with respect to carbonate, there may be a kinetic origin for the lysocline in this region.
RESUMO
Sediment traps were deployed at several depths between 660 and 3800 meters in the Panama Basin. The flux of lithogenic particles increased with increasing depth. This increase was due primarily to particles of beidellite (a smectite clay), which was identical to the clay occurring in bottom sediment on the continental slope to the west of the sediment trap mooring. The beidellite vertical flux at the Panama Basin station increased when an easterly current prevailed and decreased when the current reversed, indicating that a major portion of smectite was transported horizontally at mid-water depth to the mooring site from the nearby continental slope.
RESUMO
It has been well known that several neuropeptides may affect human behavior, and that some endocrinopathies are associated with impaired higher function of the brain. There have been increasing evidences that vasopressin has both peripheral and central effects, the latter of which is involved in memory. In experimental animals, male mice with a null mutation in the V1a receptor (V1aR) exhibit a profound impairment in social recognition and changes in anxiety-like behavior. An AVP fragment analog has been reported to facilitate memory retention and recall in mice through protein kinase C-independent pathways. In human, a few recent reports have suggested that a familial central diabetes insipidus, caused by a heterozygous mutation in the gene for vasopressin prohormone, have minor disturbances in central nervous system. Taken together, it is hypothesized that the subject with central diabetes insipidus may frequently present with an impaired cognitive ability. It is justified to examine the cognitive function, when we make a diagnosis of central diabetes insipidus and to perform a clinical study to investigate whether central diabetes insipidus may be associated with impairment of higher brain functions.
Assuntos
Cognição/fisiologia , Diabetes Mellitus/psicologia , Animais , Encéfalo/fisiopatologia , Modelos Animais de Doenças , Humanos , Masculino , Camundongos , Neuropeptídeos/fisiologia , Vasopressinas/fisiologiaRESUMO
There have been increasing evidences that atherosclerosis is not the result of diabetes mellitus, but that both type 2 diabetes mellitus and atherosclerosis may share common pathogenesis, as Stern proposed as 'common soil' hypothesis in 1995. There are several candidates for 'common soil', such as insulin resistance, vascular inflammation and endothelial dysfunction. Recently many of clinical studies have indicated that some drugs can prevent or delay the development of cardiovascular diseases (CVD). Furthermore, many studies have suggested that some classes of drugs may prevent the development of type 2 diabetes. It is to be noted that most of the drugs may have both actions, i.e., to prevent development of new diabetes and to prevent CVD. Furthermore, they are reported to inhibit inflammation or endothelial dysfunction. Taken together, it is hypothesized that the drug which may have antiatherogenetic action may also have antidiabetic action, and vice versa. This hypothesis may provide the new insights into perspectives of drug development both to prevent type 2 diabetes and to prevent CVD.
Assuntos
Aterosclerose/etiologia , Fármacos Cardiovasculares/farmacologia , Doenças Cardiovasculares/tratamento farmacológico , Diabetes Mellitus Tipo 2/etiologia , Hipoglicemiantes/farmacologia , Endotélio Vascular/metabolismo , Humanos , Inflamação , Modelos BiológicosRESUMO
Proviral integration of a simian retrovirus highly homologous to human T-cell leukemia virus type I was examined in cellular DNAs extracted from primary peripheral blood lymphocytes of 31 adult African green monkeys (Cercopithecus aethiops) that were seropositive for simian T-cell leukemia virus type I (STLV-I). Among these monkeys, one case with overt leukemia, showing pleomorphic leukemia cells similar to those in human adult T-cell leukemia (ATL), and five cases in a preleukemic state of ATL-like disease were found. Judging from the integration site of the provirus genome, primary lymphocytes of these leukemic or preleukemic cases contained monoclonally proliferated STLV-I-infected cells, whereas lymphocytes of other seropositive monkeys without hematological abnormalities were polyclonal, and those of seronegative monkeys did not contain the provirus. The restriction patterns with PstI ans SstI of most STLV-I proviruses were identical to those of the previous isolate from this species, but in three monkeys there was a deletion of one PstI site. From the correlation of the development of simian ATL-like disease with the monoclonal integration of the STLV-I provirus genome, it should be indicated that STLV-I has similar leukemogenicity to human T-cell leukemia virus type I, and so STLV-I infection in African green monkeys will be useful as an animal model of human ATL.
Assuntos
Cercopithecus , Chlorocebus aethiops , Infecções por Deltaretrovirus/veterinária , Genes Virais , Doenças dos Macacos/etiologia , Animais , Antígenos Virais/análise , Linhagem Celular , DNA Viral/análise , Deltaretrovirus/genética , Infecções por Deltaretrovirus/sangue , Infecções por Deltaretrovirus/microbiologia , Feminino , Linfócitos/microbiologia , Doenças dos Macacos/sangue , Sequências Repetitivas de Ácido Nucleico , Retroviridae/genéticaRESUMO
OBJECTIVE: To investigate the independent effect of weight change in young adulthood on the risk of prevalent NIDDM among middle-aged Japanese men. RESEARCH DESIGN AND METHODS: A case-control study was carried out in 895 male employees aged > or = 30 years of a railway company located in the vicinity of Tokyo. Adjusted odds ratios (ORs) were calculated for prevalent diabetes in each category of weight change (obtained from subjects' medical records) in young adulthood and adulthood. Adjustment for current age, initial BMI, and weight change in each age stratum was performed by the Mantel-Haenszel method or multiple logistic regression analysis. RESULTS: Weight change between 20 years of age and the age at maximum weight was not associated with the risk of NIDDM. Weight gain between 20 and 25 years of age was significantly and positively associated with the risk of NIDDM (OR 3.87 for gains > or = 10.0 kg, 2.53 for gains of 5.0-9.9%, and 3.73 for gains > or = 10.0%). On the other hand, moderate weight gain after 30 years of age was significantly inversely associated with NIDDM (OR 0.44 for gains of 5.0-9.9 kg, 0.15 for gains of 10.0-19.9%, and 0.38 for gains of 20.0-29.9%). CONCLUSIONS: Extreme weight gain between 20 and 25 years of age is a significant predictor of NIDDM, independent of current age, BMI at 20 years of age, and weight change within other age strata.
Assuntos
Envelhecimento/fisiologia , Peso Corporal , Diabetes Mellitus Tipo 2/epidemiologia , Adulto , Índice de Massa Corporal , Estudos de Casos e Controles , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Fatores de RiscoRESUMO
To investigate the influence of menopause on bone mineral density (BMD) of Japanese women, BMD of the spine and proximal femur was measured by dual-energy x-ray absorptiometry (DXA) in 220 premenopausal and 166 postmenopausal Japanese women. The peak bone density of the spine in premenopausal women was detected between 35 and 39 years of age, and that of femur before 20. Thereafter spinal and femoral BMD showed a slight decrease, but they did not show a significant decrease until menopause or menstruation became irregular. Duration of substantial bone loss at lumbar spine continued for about 10 years after menopause, but that at the femur was much longer. To investigate the effect of early menopause on bone loss, postmenopausal women were divided into two groups according to the age at onset of menopause. The BMD of postmenopausal women whose menopause occurred before 50 was significantly less over the latter part of life than that of women whose menopause occurred after 50. These results suggest that bone loss is related to menopause or irregular menstruation rather than age per se, and early menopause should be recognized as one of the risk factors for involutional osteoporosis.
Assuntos
Absorciometria de Fóton , Densidade Óssea , Menopausa , Osteoporose Pós-Menopausa/fisiopatologia , Adulto , Análise de Variância , Índice de Massa Corporal , Reabsorção Óssea , Estudos Transversais , Feminino , Colo do Fêmur , Humanos , Japão , Pessoa de Meia-Idade , Coluna VertebralRESUMO
We demonstrated the usefulness of the human TSH immunoradiometric assay for the measurement of cynomolgus monkey serum samples, and investigated the age-related changes in serum levels of TSH, T3, and T4, in laboratory-bred cynomolgus monkeys. In the females, age-related decrease in the serum TSH concentration was not observed, but decreases in serum T3 (2.1-1.4 ng/ml) and T4 (59-48 ng/ml) were observed. However, the serum T4 level of the oldest group (19 yr old) significantly increased as compared with the 11-yr-old group (56 ng/ml). In the males, age-related decreases in the serum TSH, T3, and T4 were observed. Furthermore, significant increases in serum TSH concentrations after injection of TRH were detected. The oldest group (16 yr old) showed the highest response among the five different age groups tested. However, the highest responses of T3 and T4 release from the thyroid gland after TRH injection were obtained by the 10-yr-old group. The results suggest that the sensitivity of the thyroid gland to TSH and/or the productive or releasing capacities of T3 and T4 in the thyroid gland decreased with increasing age in this primate species.